期刊文献+

无创通气慢性阻塞性肺疾病患者下呼吸道医院感染预防与控制 被引量:4

Prevention and control of hospital infection of lower respiratory tract in patients of chronic obstructive pulmonary diseases treated with noninvasive ventilation
下载PDF
导出
摘要 目的了解无创通气慢性阻塞性肺疾病(COPD)患者的医院感染情况,探讨预防和控制医院感染的有效措施。方法以2014年1~12月干预前123例无创通气COPD并Ⅱ型呼吸衰竭患者为对照组,2015年1~12月干预后112例无创通气COPD并Ⅱ型呼吸衰竭患者为干预组,对比干预前后两组患者下呼吸道医院感染的感染率,每通气日感染率,住院时间和无创通气时间,并对其下呼吸道医院感染的病原菌进行分析。结果与对照组比较,干预组的下呼吸道医院感染率[14.63%(18/123)vs 6.25%(7/123)],每通气日感染率(17‰vs 7‰),住院时间[(12.32±2.61)d vs(10.17±1.79)d]均明显下降,差异均有统计学意义(P<0.05);下呼吸道的医院感染菌主要为铜绿假单胞菌(10株,35.7%)和鲍曼不动杆菌(7株,25.0%)。结论对无创通气COPD并Ⅱ型呼吸衰竭患者采取系统的预防干预措施,可以降低下呼吸道医院感染率,缩短住院时间。 Objective To investigate the hospital infection rate of patients of chronic obstructive pulmonary diseases(COPD) treated with noninvasive ventilation, and to explore the effective measures for the control of hospital infection. Methods One hundred and twenty-three patients of COPD complicated with type Ⅱ respiratory failure treated with noninvasive ventilation before intervention from Jan. 2014 to Dec. 2014 were used as control group, and 112 COPD patients complicated with type Ⅱ respiratory failure treated with noninvasive ventilation after intervention from Jan.2015 to Dec. 2015 were enrolled as intervention group. The hospital infection rate of lower respiratory tract, the hospital infection rate of per ventilation day, the length of stay in hospital and the length of ventilation were observed and compared in the two groups. The pathogen of lower respiratory tract was analyzed. Results The hospital infection rate(14.63% vs 6.25%) of lower respiratory tract, the hospital infection rate of per ventilation day(17‰ vs 7‰) and the length of stay in hospital((12.32±2.61) d vs(10.17±1.79) d) decreased significantly in the intervention group as compared with those in the control group(P<0.05). Pseudomonas aeruginosa(n=10, 35.7%) and Acinetobacter baumannii(n=7, 25%) were the main pathogens. Conclusion The standard interventions may reduce the hospital infection in COPD patients complicated with type Ⅱ respiratory failure treated with noninvasive ventilation, and also shorten the length of stay in hospital.
出处 《海南医学》 CAS 2016年第18期2993-2995,共3页 Hainan Medical Journal
基金 广东省广州市番禺区科技计划医疗卫生项目(编号:2015-Z03-26)
关键词 无创通气 慢性阻塞性肺疾病 呼吸衰竭 下呼吸道 医院感染 Noninvasive ventilation Chronic obstructive pulmonary diseases Respiratory failure Lower respi ratory tract Hospital infection
  • 相关文献

参考文献5

二级参考文献30

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3057
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 3中华人民共和国卫生部.医院感染诊断标准(试行).(2001年1月2日颁布).南京:东南大学出版社,2001.
  • 4Clinical and Laboratory Standards Institute CLSI. 2006. Performance standards for antimicrobial susceptibility testing [ S ]. sixteenth informational supplement. Wayne, Pa.
  • 5Nseir S, Di Pompeo C, Cavestri B, et al. Multiple diaig-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome. Crit Care Med ,2006 ,34 : 2959-2966.
  • 6Wilson R. Bacteria, antibiotics and COPD. Eur Respir J, 2001,17 : 995-1007.
  • 7Ram FS, Rodrignez-Roisin R, Granados-Navarrete A, et al. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev ,2006,19 : CD004403.
  • 8Marquette CH, Herengt F, Mathieu D, et al. Diagnostic of pneumonia in mechanically ventilated patients, repeatability of the protected specimen brush. Am Rev Respir Dis,1993,147:211-214.
  • 9Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis, 2006,43 : S49-S56.
  • 10Resende JC, de Resende MA, Saliba JL. Prevalence of Candida spp. in hospitalized patients and their risk factors. Mycoses, 2002,45 : 306 -312.

共引文献94

同被引文献29

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部